PMID- 25031977
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20140717
LR  - 20240503
IS  - 2150-0878 (Print)
IS  - 2150-0886 (Electronic)
IS  - 2150-0878 (Linking)
VI  - 4
IP  - 1
DP  - 2013 Jan
TI  - Screening for prostate cancer: the debate continues.
PG  - 16-21
AB  - Other than skin cancer, prostate cancer is the most frequently diagnosed cancer 
      in men, and it is the second leading cause of cancer-related death for males in 
      the United States. Screening for prostate cancer using prostate-specific antigen 
      testing became widely used by the late 1980s, augmenting the digital rectal exam. 
      This led to a decline in the percentage of prostate cancer cases that were 
      metastatic at diagnosis and a decrease in prostate cancer mortality. But some 
      argued it led to overtreatment of prostate cancers as well. Recently, the U.S. 
      Preventive Services Task Force (USPSTF) issued recommendations against routine 
      prostate cancer screening in asymptomatic patients. The recent recommendations 
      have created much controversy among medical professionals, patient advocate 
      groups, and the general public. Most prostate cancer screening recommendations 
      from professional organizations agree that an informed discussion and review of 
      each individual patient's clinical situation should drive the decision to screen 
      or not to screen, but the current USPSTF recommendations largely remove patient 
      and provider autonomy in this regard. They do not contribute toward personalized 
      screening based on individualized patient risk profiles, characteristics, and 
      preferences.
FAU - Matrana, Marc R
AU  - Matrana MR
AD  - University of Texas MD Anderson Cancer Center, Houston, Texas.
FAU - Atkinson, Bradley
AU  - Atkinson B
AD  - University of Texas MD Anderson Cancer Center, Houston, Texas.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - J Adv Pract Oncol
JT  - Journal of the advanced practitioner in oncology
JID - 101550346
PMC - PMC4093374
EDAT- 2013/01/01 00:00
MHDA- 2013/01/01 00:01
PMCR- 2013/01/01
CRDT- 2014/07/18 06:00
PHST- 2014/07/18 06:00 [entrez]
PHST- 2013/01/01 00:00 [pubmed]
PHST- 2013/01/01 00:01 [medline]
PHST- 2013/01/01 00:00 [pmc-release]
AID - 10.6004/jadpro.2013.4.1.2 [doi]
PST - ppublish
SO  - J Adv Pract Oncol. 2013 Jan;4(1):16-21. doi: 10.6004/jadpro.2013.4.1.2.